Advertisement
Advertisement
NEOG
Neogen Corp
11.76
USDSponsored
+0.08
+0.68%
Nov 06, 15:59 UTC -5
Closed
After-Market
11.77
+0.01
+0.04%
Neogen Corp (NEOG) Earnings
NEOG Earnings Reports
Positive Surprise Ratio
NEOG beat 15 of 43 last estimates.
35%
Next Report
Date of Next Report
Jan 06, 2027
Estimate for Q2 27 (Revenue/ EPS)
$227.51M
/-$0.05
Implied change from Q1 27 (Revenue/ EPS)
+2.11%
/--
Implied change from Q2 26 (Revenue/ EPS)
+0.98%
/-150.00%
Neogen Corp earnings per share and revenue
On Oct 06, 2026, NEOG reported earnings of -0.05 USD per share (EPS) for Q1 27, beating the estimate of -0.07 USD, resulting in a 29.97% surprise. Revenue reached 222.80 million, compared to an expected 212.34 million, with a 4.93% difference. The market reacted with a -2.34% price change (close before vs. close after earnings).
Looking ahead to Q2 27, 5 analysts forecast an EPS of -0.05 USD, with revenue projected to reach 227.51 million USD, implying an increase of 0.00% EPS, and increase of 2.11% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
BillionToOne, Inc. Class A Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.14
Actual
$0.32
Surprise
+115.34%
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.36
Actual
$0.40
Surprise
+10.04%
ICU Medical Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
$2.17
Actual
$2.44
Surprise
+11.93%
Prestige Consumer Healthcare Inc.
Report Date
Nov 05, 2026 For Q2 27
Estimate
$1.08
Actual
$1.12
Surprise
+4.28%
Trulieve Cannabis Corp.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.07
Actual
$0.09
Surprise
+26.05%
PERRIGO COMPANY PLC
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.50
Actual
$0.60
Surprise
+18.44%
LeMaitre Vascular, Inc.
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.70
Actual
$0.65
Surprise
-7.14%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.05
Actual
-$0.03
Surprise
+48.10%
Apyx Medical Corporation Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.04
Surprise
+57.98%
Nephros Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.02
Actual
$0.05
Surprise
+110.08%
FAQ
What were Neogen Corp's earnings and revenue for the latest quarter Q1 2027?
For Q1 2027, Neogen Corp reported EPS of -$0.05, beating estimates by 29.97%, and revenue of $222.80M, 4.93% above expectations.
How did the market react to Neogen Corp's Q1 2027 earnings?
The stock price moved down -2.34%, changed from $11.96 before the earnings release to $11.68 the day after.
When is Neogen Corp expected to report next?
The next earning report is scheduled for Jan 06, 2027.
What are the forecasts for Neogen Corp's next earnings report?
Based on 5
analysts, Neogen Corp is expected to report EPS of -$0.05 and revenue of $227.51M for Q2 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.